Furthermore, salivary interleukin-34 (IL-34) levels are elevated in AD patients and are inversely associated with Mini-Mental State Examination (MMSE) scores, indicating a potential role in cognitive decline [148]. Here, IL34 is linked to Alzheimer disease.